Carol and John Cromer ’63 Family Endowed Associate Professor
Drug Delivery, Biomaterials, and Nanotechnology
Email: larsenj@clemson.edu
Phone: 864-656-2621
Office: 209 Earle Hall
Website: https://www.thelarsenlab.com/
Ph.D., Auburn University
B.S., University of Virginia
Katterman, C.; Pierce, C.; Larsen, J.; Combining Nanoparticle Shape Modulation and Polymersome Technology in Drug Delivery. ACS Applied Bio Materials 2021. 8 Mar 2021. DOI: https://doi.org/10.1021/acsabm.1c00203
Maghak, L.; Larsen, J.M. Intact or In Pieces? A Look at How Clinically-Approved, Biodegradable Block Co-Polymers Affect Blood Components. ACS Biomaterials Science & Engineering 2020 6 (9), 4846-4850; DOI: 10.1021/acsbiomaterials.0c00680
Pitman, M. A.; Larsen, J. M. Characterization of Self-Assembling Nanostructures in Whole Blood. Analytical Methods. 3 Apr 2020. DOI: https://doi.org/10.1039/D0AY00170H
Iqbal, S., Blenner, M., Alexander-Bryant, A., Larsen, J. Polymersomes for Therapeutic Delivery of Protein and Nucleic Acid Macromolecules: From Design to Therapeutic Applications. Biomacromolecules. 2020. DOI: https://doi.org/10.1021/acs.biomac.9b01754
L'Amoreaux, N., Ali, A., Iqbal, S., Larsen, J. Persistent Prolate Polymersomes for Enhanced Co-Delivery of Hydrophilic and Hydrophobic Drugs. Nanotechnology. Accepted Manuscript online 15 January 2020. PMCID: 31940601 DOI: https://doi.org/10.1088/1361-6528/ab6bf1
Kelly, J.M.; Martin, D.R.; Byrne, M.E. “Polyethylene glycol-b-Poly(lactic acid) Polymersomes as Vehicles for Enzyme Replacement Therapy”, Nanomedicine, 2591-2606, (2017). PMCID: 29111890
Kelly, J.M.; Bradbury, A. M., Martin, D.R., Byrne, M.E. “Emerging Therapies for Neuropathic Lysosomal Storage Disorders”, Progress in Neurobiology, 152, 166-180 (2017). PMCID: 27725193